IP Library Granted Patent US 10,507,191
Granted Patent B2
US 10,507,191 · App. 15/942,471 · Granted Dec 17, 2019

Materials and methods for controlling infections

Inventors: Carolyn L. Twomey (Lawrenceville, GA); Gareth Clarke (Lawrenceville, GA); Samuel Zaidspiner (Lawrenceville, GA)
Assignee: INNOVATION TECHNOLOGIES, INC.
A61K31/155A61F13/00063A61K9/0019A61K9/0043A61K9/0073A61K9/0085A61K9/08A61K31/191A61K45/06A61L15/44A61L17/005A61L27/54A61L29/08A61L29/16A61L31/08A61L31/16A61M25/0017A61K2300/00A61L2300/206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,507,191
App. No.
15/942,471
Granted
Dec 17, 2019
Kind
B2
Abstract

The subject invention provides materials methods for reducing infections in subjects. The materials methods utilize chlorhexidine, which has been found to be surprisingly non-toxic. The lack of toxicity facilitates the use of chlorhexidine in contexts that were not previously thought to be possible.

Claims (11)

1. A system for minimally invasive surgery (MIS) wherein said system comprises a tube that is adapted for receiving a chlorhexidine gluconate solution from a reservoir containing said solution and said tube is further adapted to deliver the chlorhexidine gluconate solution to a site in a subject where surgery is being performed, wherein said system further comprises at least one tube for an optical component and/or for removal of fluids; wherein said system further comprises a reservoir containing a solution of 0.1% or less of chlorhexidine gluconate; wherein said reservoir is operably connected to said tube; and wherein said chlorhexidine gluconate solution consists of an aqueous solution of chlorhexidine gluconate and water.

2. The system of claim 1 , wherein the concentration of chlorhexidine gluconate is about 0.05% or less.

3. The system of claim 1 , wherein the reservoir is a bag.

4. A method of performing MIS wherein said method comprises using a system of claim 1 to deliver a solution of chlorhexidine gluconate to a surgical site.

5. The method of claim 4 , used to inhibit the growth of biofilm at the surgical site.

6. The method of claim 4 , wherein the concentration of chlorhexidine gluconate is about 0.05% or less.

7. The method of claim 4 , wherein said reservoir is a bag.

8. The system, according to claim 1 , which is a sterile, closed system.

9. The system, according to claim 1 , wherein the concentration of chlorhexidine gluconate is from 0.02% to 0.1%.

10. The method, according to claim 4 , wherein the concentration of chlorhexidine gluconate is from 0.02% to 0.1%.

11. The method, according to claim 4 , wherein said chlorhexidine gluconate solution consists of an aqueous solution of chlorhexidine gluconate and water.

Assignments (2)
SECURITY INTEREST Recorded Aug 21, 2024
From: INNOVATION TECHNOLOGIES, INC.
To: OXFORD FINANCE LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 068360/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2018
From: TWOMEY, CAROLYN L.; CLARKE, GARETH; ZAIDSPINER, SAMUEL
To: INNOVATION TECHNOLOGIES, INC.
Reel/Frame 045803/0037 →
Continuity (7)
Continuation 15803279 · Nov 3, 2017
Continuation 15803255 · Nov 3, 2017
Continuation 15173089 · Jun 3, 2016
Continuation 15168176 · May 30, 2016
Continuation 14568925 · Dec 12, 2014
Provisional Application 61915281 · Dec 12, 2013
Related Publication 20180221311A1 · Aug 9, 2018